Press Releases | Stay on top of breaking Illumina news
Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023 Jan 5, 2024 Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
News Center | News and Press about Illumina
Illumina featured discussions with leading experts on the future of cancer care in China. How Illumina’s Erin Imsand and her team helped develop reagents that can be stored at room temperature. The comprehensive method provides improved detection and greater insight on the complex disease that impacts millions of people worldwide.
Illumina, Inc. (ILMN) Latest Stock News & Headlines - Yahoo …
Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.
Illumina in the News | What others say about us and our …
Jan 10, 2015 · Illumina Helped the World Fight COVID-19. Now, CEO Francis deSouza Has Monkeypox in His Sights. Researchers Are Discovering How to Predict – and Maybe Treat — Pregnancy Complications Early On. Omicron Undetected in U.S. So Far, Testing Biden Sequencing Plan. ESG in Genomics: Where to start?
What's Going On With Illumina Stock On Monday? - Yahoo Finance
13 hours ago · Most recently, Illumina reported third-quarter adjusted EPS of $1.14, beating the consensus of $0.88, with sales of $1.08 billion, almost in line with the consensus of $1.08 billion. “During the ...
Illumina, Inc. - Illumina acquires Fluent BioSciences to accelerate ...
Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.
Illumina CEO deSouza resigns after proxy battle with Icahn
Jun 11, 2023 · Illumina CEO Francis deSouza stepped down on Sunday, marking a victory for activist investor Carl Icahn and heightening expectations that it could unwind its controversial $7.1 billion...
Illumina announces strategy to accelerate value creation
Aug 13, 2024 · Illumina, Inc. (NASDAQ: ILMN) today is hosting a Strategy Update for investors to present its strategy and three-year financial outlook that features accelerating revenue growth and significant margin expansion.
San Diego has a new CEO in town. Here’s what financial analysts …
Sep 7, 2023 · Illumina, San Diego’s DNA-sequencing giant, has a new boss. Illumina’s board tapped Jacob Thaysen, a seasoned life science executive, to lead the $25 billion biotechnology company starting on...
US securities regulator probes Illumina over Grail deal
Aug 11, 2023 · The U.S. Securities and Exchange Commission (SEC) has begun an investigation into Illumina's $7.1 billion acquisition of cancer detection test maker Grail , the gene sequencing company said in...
- Some results have been removed